{"transactions":[{"id":1442916,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T17:31:53.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."}],"balance_after":29547,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":385},"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442915,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T17:31:53.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals."}],"balance_after":29162,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":385},"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442914,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T17:31:53.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":2307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027."}],"balance_after":28777,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2307},"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442913,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-02T17:31:53.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":3077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025."}],"balance_after":26470,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3077},"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442912,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-02T17:31:53.000Z","date":"2024-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":282,"price":1.71,"value":482.22,"ownership":{"direct":true},"balance_after":6482,"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442911,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-02T17:31:53.000Z","date":"2024-07-10","kind":"exercise","planned":false,"acquired":true,"shares":644,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":6764,"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442910,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-02T17:31:53.000Z","date":"2024-04-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":518,"price":2.79,"value":1445.22,"ownership":{"direct":true},"balance_after":6120,"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1442909,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-02T17:31:53.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":1675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."}],"balance_after":6638,"source":{"system":"sec-edgar","filing":"0000897069-24-001613","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924001613/form4.xml","form_type":"4"}},{"id":1542578,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-12T16:57:56.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":1675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of vested restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":24037,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1675},"source":{"system":"sec-edgar","filing":"0000897069-24-000923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924000923/form4.xml","form_type":"4"}},{"id":1542577,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-12T16:57:56.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":518,"price":2.79,"value":1445.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":6120,"source":{"system":"sec-edgar","filing":"0000897069-24-000923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924000923/form4.xml","form_type":"4"}},{"id":1542576,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-12T16:57:56.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":1675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of vested restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":6638,"source":{"system":"sec-edgar","filing":"0000897069-24-000923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706924000923/form4.xml","form_type":"4"}},{"id":1761180,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-12T17:58:48.000Z","date":"2023-10-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.33,"value":4950.0,"ownership":{"direct":true},"balance_after":99250,"source":{"system":"sec-edgar","filing":"0000897069-23-001464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706923001464/form4.xml","form_type":"4"}},{"id":1762589,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-10T16:51:21.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0.24,"value":5400.0,"ownership":{"direct":true},"balance_after":84250,"source":{"system":"sec-edgar","filing":"0000897069-23-001436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000089706923001436/form4.xml","form_type":"4"}},{"id":2022724,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-10T17:20:19.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":12500,"price":0.8,"value":10000.0,"ownership":{"direct":true},"balance_after":61750,"source":{"system":"sec-edgar","filing":"0001567619-23-002403","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761923002403/doc1.xml","form_type":"4"}},{"id":2067778,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T17:42:10.000Z","date":"2023-01-01","kind":"grant","acquired":false,"shares":96150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock units represents a contingent right to receive one share of the Issuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock units represents a contingent right to receive one share of the Issuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."}],"balance_after":518431,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":96150},"source":{"system":"sec-edgar","filing":"0001567619-23-000324","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761923000324/doc1.xml","form_type":"4"}},{"id":2067777,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T17:42:10.000Z","date":"2023-01-01","kind":"grant","acquired":false,"shares":69667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death."}],"balance_after":422281,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":69667},"source":{"system":"sec-edgar","filing":"0001567619-23-000324","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761923000324/doc1.xml","form_type":"4"}},{"id":2067776,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T17:42:10.000Z","date":"2022-12-31","kind":"grant","acquired":false,"shares":12951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death. These restricted stock units vest on date grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death. These restricted stock units vest on date grant."}],"balance_after":352614,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12951},"source":{"system":"sec-edgar","filing":"0001567619-23-000324","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761923000324/doc1.xml","form_type":"4"}},{"id":2142250,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-05T16:40:57.000Z","date":"2022-09-30","kind":"grant","acquired":false,"shares":12950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Previous filing inadvertently underreported derivative securities beneficially owned by the reporting person."}],"balance_after":339663,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12950},"source":{"system":"sec-edgar","filing":"0001567619-22-018275","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922018275/doc1.xml","form_type":"4/A","original_submission_date":"2022-10-03"}},{"id":2147341,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-10-03T16:51:12.000Z","date":"2022-06-30","kind":"grant","acquired":false,"shares":23947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":326713,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":23947},"source":{"system":"sec-edgar","filing":"0001567619-22-018057","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922018057/doc1.xml","form_type":"4"}},{"id":2190885,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T16:28:04.000Z","date":"2022-08-05","kind":"tax_withholding","acquired":false,"shares":2462,"price":3.17,"value":7804.54,"ownership":{"direct":true},"balance_after":49250,"source":{"system":"sec-edgar","filing":"0001567619-22-015307","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922015307/doc1.xml","form_type":"4"}},{"id":2190884,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-09T16:28:04.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":7601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":51712,"source":{"system":"sec-edgar","filing":"0001567619-22-015307","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922015307/doc1.xml","form_type":"4"}},{"id":2214747,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-05T17:35:40.000Z","date":"2022-06-30","kind":"grant","acquired":false,"shares":23947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":326713,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":23947},"source":{"system":"sec-edgar","filing":"0001567619-22-013682","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922013682/doc1.xml","form_type":"4"}},{"id":2299439,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-11T17:54:14.000Z","date":"2022-04-01","kind":"grant","acquired":false,"shares":247841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the \"Plan\") to increase the authorized shares under the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the \"Plan\") to increase the authorized shares under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The previous filing understated this number. This new total accurately reflects the cumulative total of Restricted Stock Units for the reporting person."}],"balance_after":302766,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":247841},"source":{"system":"sec-edgar","filing":"0001567619-22-008365","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922008365/doc1.xml","form_type":"4"}},{"id":2308334,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T17:46:31.000Z","date":"2022-03-31","kind":"grant","acquired":false,"shares":10715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":37781,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10715},"source":{"system":"sec-edgar","filing":"0001567619-22-007982","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922007982/doc1.xml","form_type":"4"}},{"id":2308333,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T17:46:31.000Z","date":"2021-11-01","kind":"grant","acquired":false,"shares":4286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":27066,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4286},"source":{"system":"sec-edgar","filing":"0001567619-22-007982","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922007982/doc1.xml","form_type":"4"}},{"id":2441736,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T17:21:16.000Z","date":"2021-12-31","kind":"grant","acquired":false,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance."}],"balance_after":22780,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001567619-22-000766","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922000766/doc1.xml","form_type":"4/A","original_submission_date":"2022-01-04"}},{"id":2441609,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-06T16:07:19.000Z","date":"2021-09-30","kind":"grant","acquired":false,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance."}],"balance_after":16058,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6024},"source":{"system":"sec-edgar","filing":"0001567619-22-000724","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922000724/doc1.xml","form_type":"4/A","original_submission_date":"2021-10-04"}},{"id":2449386,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T17:27:31.000Z","date":"2021-12-31","kind":"grant","acquired":false,"shares":6722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":6722,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6722},"source":{"system":"sec-edgar","filing":"0001567619-22-000294","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761922000294/doc1.xml","form_type":"4"}},{"id":2552095,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-04T16:38:19.000Z","date":"2021-09-30","kind":"grant","acquired":false,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":6024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6024},"source":{"system":"sec-edgar","filing":"0001567619-21-017827","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921017827/doc1.xml","form_type":"4"}},{"id":2610084,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-09T16:38:47.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":7601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":44111,"source":{"system":"sec-edgar","filing":"0001567619-21-014749","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921014749/doc1.xml","form_type":"4"}},{"id":2637046,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T16:31:38.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":1907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":10034,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001567619-21-013183","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921013183/doc1.xml","form_type":"4"}},{"id":2637045,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T16:31:38.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":12858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest upon achievement of certain performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest upon achievement of certain performance goals."}],"balance_after":12858,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12858},"source":{"system":"sec-edgar","filing":"0001567619-21-013183","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921013183/doc1.xml","form_type":"4"}},{"id":2637044,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-09T16:31:38.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":8572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in two equal installments beginning July 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units vest in two equal installments beginning July 1, 2022."}],"balance_after":8572,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8572},"source":{"system":"sec-edgar","filing":"0001567619-21-013183","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921013183/doc1.xml","form_type":"4"}},{"id":2658851,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-22T17:09:57.000Z","date":"2021-06-21","kind":"purchase","acquired":true,"shares":1000,"price":6.81,"value":6810.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $6.72 to $6.89, inclusive.  The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":36510,"source":{"system":"sec-edgar","filing":"0001567619-21-012484","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921012484/doc1.xml","form_type":"4"}},{"id":2673987,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-10T17:06:35.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":8127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death."}],"balance_after":8127,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8127},"source":{"system":"sec-edgar","filing":"0001567619-21-011980","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761921011980/doc1.xml","form_type":"4"}},{"id":3013383,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T17:33:16.000Z","date":"2020-10-01","kind":"purchase","acquired":true,"shares":6000,"price":4,"value":24000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amended Form 4 is being filed to correct the purchase price for the reported transaction."}],"balance_after":47248,"source":{"system":"sec-edgar","filing":"0001567619-20-017592","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761920017592/doc1.xml","form_type":"4/A","original_submission_date":"2020-10-05"}},{"id":3013382,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T16:43:54.000Z","date":"2020-10-01","kind":"purchase","acquired":true,"shares":6000,"price":2.1,"value":12600.0,"ownership":{"direct":true},"balance_after":47248,"source":{"system":"sec-edgar","filing":"0001567619-20-017574","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681718/000156761920017574/doc1.xml","form_type":"4"}},{"id":3493384,"issuer":{"id":87144,"kind":"organization","name":"GSE SYSTEMS INC","symbol":"GVP"},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-12T16:23:39.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":25316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent restricted share units granted pursuant to a Restricted Share Unit Agreement between Mr. Stanker and the Issuer and are subject to forfeiture. The restricted share units awarded will vest at the earlier of June 11, 2020 or the date of the Issuer's 2020 Annual Meeting of Stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These restricted share units were granted to Mr. Stanker for his service as a member of the Board of Directors of the Issuer."}],"balance_after":48118,"source":{"system":"sec-edgar","filing":"0001567619-19-013279","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944480/000156761919013279/doc1.xml","form_type":"4"}},{"id":3896065,"issuer":{"id":87144,"kind":"organization","name":"GSE SYSTEMS INC","symbol":"GVP"},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T17:13:13.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":7911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent restricted share units granted pursuant to a Restricted Share Unit Agreement between Mr. Stanker and the Issuer and are subject to forfeiture. The restricted share units awarded will vest at the earlier of June 12, 2019 or the date of the Issuer's 2019 Annual Meeting of Stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These restricted share units were granted to Mr. Stanker for his service as a member of the Board of Directors of the Issuer."}],"balance_after":22802,"source":{"system":"sec-edgar","filing":"0001140361-18-028441","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944480/000114036118028441/doc1.xml","form_type":"4"}},{"id":4282820,"issuer":{"id":87144,"kind":"organization","name":"GSE SYSTEMS INC","symbol":"GVP"},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-14T16:21:55.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":7352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares of common stock represent restricted share units granted pursuant to a Restricted Share Unit Agreement between Mr. Stanker and the Issuer and are subject to forfeiture. The restricted share units awarded will vest at the earlier of June 7, 2018 or the date of the Issuer's 2018 Annual Meeting of Stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These restricted share units were granted to Mr. Stanker for his service as a member of the Board of Directors of the Issuer."}],"balance_after":14891,"source":{"system":"sec-edgar","filing":"0001140361-17-024983","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944480/000114036117024983/doc1.xml","form_type":"4"}},{"id":4282819,"issuer":{"id":87144,"kind":"organization","name":"GSE SYSTEMS INC","symbol":"GVP"},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-14T16:21:55.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":1923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Common Stock granted to Mr. Stanker on June 12, 2017, in partial compensation for the Mr. Stanker's service as a member of the Issuer's Board of Directors between March 1, 2017 and June 12, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Common Stock granted to Mr. Stanker on June 12, 2017, in partial compensation for the Mr. Stanker's service as a member of the Issuer's Board of Directors between March 1, 2017 and June 12, 2017."}],"balance_after":7539,"source":{"system":"sec-edgar","filing":"0001140361-17-024983","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944480/000114036117024983/doc1.xml","form_type":"4"}},{"id":4526291,"issuer":{"id":87144,"kind":"organization","name":"GSE SYSTEMS INC","symbol":"GVP"},"owners":[{"id":88534,"kind":"person","name":"Stanker James H","position":1,"cik":"0001681718","reported_name":"Stanker James H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-12T17:07:54.000Z","date":"2016-12-08","kind":"grant","acquired":true,"shares":5616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent restricted share units granted pursuant to a Restricted Share Unit Agreement between Mr. Stanker and the Issuer and are subject to forfeiture. The restricted share units awarded will vest at the earlier of June 7, 2017 or the date of the Issuer's 2017 Annual Meeting of Stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These restricted share units were granted to Mr. Stanker for his service as a member of the Board of Directors of the Issuer."}],"balance_after":5616,"source":{"system":"sec-edgar","filing":"0001140361-16-089399","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944480/000114036116089399/doc1.xml","form_type":"4"}}]}